User profiles for Katie L. Kunze

Katie Kunze

Principal Biostatistician, Mayo Clinic Arizona
Verified email at mayo.edu
Cited by 2792

Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients

MJ Joyner, KA Bruno, SA Klassen, KL Kunze… - Mayo Clinic …, 2020 - Elsevier
Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …

[HTML][HTML] Early safety indicators of COVID-19 convalescent plasma in 5000 patients

…, KJ Andersen, DO Hodge, KL Kunze… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …

[HTML][HTML] Convalescent plasma antibody levels and the risk of death from Covid-19

…, AM Klompas, ER Lesser, KL Kunze… - … England Journal of …, 2021 - Mass Medical Soc
Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …

Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience

…, KA Bruno, AM Klompas, ER Lesser, KL Kunze… - medrxiv, 2020 - medrxiv.org
Importance Passive antibody transfer is a longstanding treatment strategy for infectious
diseases that involve the respiratory system. In this context, human convalescent plasma has …

Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome

…, KL Kunze, M Golafshar, PLS Uson, L Mountjoy… - JAMA …, 2021 - jamanetwork.com
Importance Hereditary factors play a key role in the risk of developing several cancers.
Identification of a germline predisposition can have important implications for treatment decisions, …

[HTML][HTML] Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study

JW Senefeld, PW Johnson, KL Kunze, EM Bloch… - PLoS …, 2021 - journals.plos.org
Background The United States (US) Expanded Access Program (EAP) to coronavirus disease
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …

[HTML][HTML] Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors

KL Kunze, PW Johnson, N van Helmond… - Nature …, 2021 - nature.com
Successful therapeutics and vaccines for coronavirus disease 2019 (COVID-19) have
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…

[HTML][HTML] Germline cancer susceptibility gene testing in unselected patients with colorectal adenocarcinoma: a multicenter prospective study

…, S Gurudu, H Singh, M Klint, KL Kunze… - Clinical …, 2022 - Elsevier
Background & Aims Hereditary factors play a role in the development of colorectal cancer (CRC).
Identification of germline predisposition can have implications on treatment and cancer …

[HTML][HTML] Rates among hospitalized patients with COVID-19 treated with Convalescent plasma: A systematic review and meta-analysis

…, V Herasevich, AM Klompas, KL Kunze… - … : Innovations, Quality & …, 2023 - Elsevier
Objective To examine the association of COVID-19 convalescent plasma transfusion with
mortality and the differences between subgroups in hospitalized patients with COVID-19. …

Learning style preferences of practicing nurses

K Mangold, KL Kunze, MM Quinonez… - Journal for nurses in …, 2018 - journals.lww.com
Nursing professional development practitioners are encouraged to consider incorporating
preferred learning styles into professional development programs. However, conclusive …